Depending on whether you are enrolled in Part A or Part B, your total participation in this study will last either 2 or 3 months.
There will first be a screening visit to confirm your eligibility in the 28 days before you receive study drug or placebo.
After screening, Part A lasts 22 days with 5 visits to the study site.
After screening, Part B lasts 2 months with 9 visits to the study site and 4 phone calls.